ArticleFrontiers in oncology2022

Establishment and Validation of Pre-Therapy Cervical Vertebrae Muscle Quantification as a Prognostic Marker of Sarcopenia in Patients With Head and Neck Cancer.

Brennan Olson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.